In the latest trading session, Tilray, Inc. (TLRY - Free Report) closed at $46.40, marking a +0.76% move from the previous day. This move outpaced the S&P 500's daily loss of 0.3%. Meanwhile, the Dow lost 0.54%, and the Nasdaq, a tech-heavy index, lost 0.41%.
Coming into today, shares of the company had lost 19.28% in the past month. In that same time, the Medical sector lost 3.82%, while the S&P 500 lost 0.43%.
Investors will be hoping for strength from TLRY as it approaches its next earnings release, which is expected to be May 14, 2019.
Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of -$0.89 per share and revenue of $200.92 million. These totals would mark changes of -56.14% and +365.85%, respectively, from last year.
It is also important to note the recent changes to analyst estimates for TLRY. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection has moved 13.83% higher. TLRY is currently sporting a Zacks Rank of #4 (Sell).
The Medical - Drugs industry is part of the Medical sector. This group has a Zacks Industry Rank of 88, putting it in the top 35% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow TLRY in the coming trading sessions, be sure to utilize Zacks.com.